Direxion Daily Healthcare Bull 3X Shares
CURE
NYSE Arca
| Weiss Ratings | CURE - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Reward Grade | C | |||
| Risk Index | Fair | |||
| Risk Grade | C- | |||
| Valuation | CURE - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Price | $79.36 | |||
| Company Info | CURE - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | Direxion Funds | |||
| Manager/Tenure (Years) | Paul Brigandi (14), Tony Ng (9) | |||
| Website | http://www.direxionfunds.com | |||
| Phone Number | 646-572-3390 | |||
| Fund Information | CURE - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | Direxion Daily Healthcare Bull 3X Shares | |||
| Category | Trading--Leveraged Equity | |||
| Sub-Category | Trading Tools | |||
| Prospectus Objective | Specialty - Health | |||
| Inception Date | Jun 15, 2011 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | -- | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | CURE - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 1.36% | |||
| Dividend | CURE - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 2.11% | |||
| Asset Allocation | CURE - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 22.03% | |||
| Stock | 77.97% | |||
| U.S. Stock | 77.97% | |||
| Non-U.S. Stock | 0.00% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | 0.00% | |||
| Price History | CURE - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -1.12% | |||
| 30-Day Total Return | 11.41% | |||
| 60-Day Total Return | -0.76% | |||
| 90-Day Total Return | 4.52% | |||
| Year to Date Total Return | -13.13% | |||
| 1-Year Total Return | -43.20% | |||
| 2-Year Total Return | -17.74% | |||
| 3-Year Total Return | -11.30% | |||
| 5-Year Total Return | 28.15% | |||
| Price | CURE - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | $80.90 | |||
| 1-Month Low Price | $67.57 | |||
| 1-Month High Price | $82.23 | |||
| 52-Week Low Price | $67.57 | |||
| 52-Week Low Price (Date) | Aug 07, 2025 | |||
| 52-Week High Price | $141.15 | |||
| 52-Week High Price (Date) | Sep 16, 2024 | |||
| NAV | CURE - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| 1-Month Low NAV | $67.47 | |||
| 1-Month High NAV | $82.37 | |||
| 52-Week Low NAV | $67.47 | |||
| 52-Week Low NAV (Date) | Aug 07, 2025 | |||
| 52-Week High NAV | $141.22 | |||
| 52-Week High Price (Date) | Sep 03, 2024 | |||
| Beta / Standard Deviation | CURE - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.68 | |||
| Standard Deviation | 41.86 | |||
| Balance Sheet | CURE - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 165.47M | |||
| Operating Ratios | CURE - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 0.93% | |||
| Turnover Ratio | 23.00% | |||
| Performance | CURE - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 7.52% | |||
| Last Bear Market Total Return | -20.67% | |||